Primary pericardial mesothelioma

Lung Cancer. 2007 Oct 11; [Epub ahead of print] [Link] Santos C, Montesinos J, Castañer E, Sole JM, Baga R. Hospital de Sabadell, Corporació Parc Taulí, Institut Universitari, Sabadell-Barcelona, Spain. Abstract Primary pericardial mesothelioma is a rare clinical entity; about 150 cases have been described in literature. It is a highly aggressive tumour with global…

Read More

Malignant mediastinal tumor with bone formation–mesothelioma or sarcoma?

Journal of Thoracic Oncology. 2007 Oct;2(10):983-4 [Link] Hillerdal G, Elmberger G. Department of Lung Medicine, Karolinska University Hospital, Stockholm, Sweden. gunnar.hillerdal@karolinska.se Abstract Mesothelioma can occur in different variants, some of which are difficult or impossible to differentiate from sarcomas. There are scattered reports of sarcomatous mesotheliomas that have osteogenic properties. Here, we report a 57-year…

Read More

Report of a Case of Pericardial Mesothelioma with Liver Metastases Responding Well to Pemetrexed and Platinum-Based Chemotherapy

Journal of Thoracic Oncology. 2007 Aug;2(8):780-1. [Link] Doval DC, Pande SB, Sharma JB, Rao SA, Prakash N, Vaid AK. Department of Medical Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India. dcdoval@yahoo.com Abstract Pericardial mesothelioma remains a disease with a bleak prognosis. We report the case of a patient with metastases to liver and good response…

Read More

Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial

Expert Review of Anticancer Therapy May 2007, Vol. 7, No. 5, Pages 635-640 [Link] Roberta Ferraldeschi, Nick Thatcher and Paul Lorigan Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK. roberta_ferraldeschi@yahoo.com Correspondence: Dr JM Vignaud, MD, Departement de Pathologie, Hôpital Central, CHU de Nancy, 54035 Nancy Cedex, France. E-mail: jm.vignaud@chu-nancy.fr Abstract Pemetrexed is a…

Read More

Intracavitary mass as the initial manifestation of primary pericardial mesothelioma: a case report

Angiology. 2007 Apr-May;58(2):255-8. [Link] Peregud-Pogorzelska M, Kaźmierczak J, Wojtarowicz A. Department of Cardiology, Pomeranian Medical University, Szczecin, Poland. mperegud@iscnet.pl Abstract A 31-year-old woman presented with a 3-month history of progressing fatigue and effort dyspnea. Echocardiography depicted a tumor within the free wall of the right ventricle and right atrium, located on both sides of the…

Read More

Pemetrexed as second-line treatment in malignant pleural mesothelioma after platinum-based first-line treatment

Journal of Thoracic Oncology. 2(2):147-152, February 2007. [Link] Sørensen JB, Sundstrøm S, Perell K, Thielsen AK. Department of Oncology, Finsen Centre/National University Hospital, Copenhagen, Denmark. jbsonk@rh.dk Abstract Introduction: Pemetrexed is active as first-line treatment of malignant pleural mesothelioma. The objective was to evaluate its activity as second-line treatment. Methods: Patients had disease progression of malignant…

Read More

Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results

Lung Cancer. 2007 Jul;57(1):89-95. Epub 2007 Apr 2. [Link] Rea F, Marulli G, Bortolotti L, Breda C, Favaretto AG, Loreggian L, Sartori F. Division of Thoracic Surgery, University of Padua, Policlinico di Padova, Italy. federico.rea@unipd.it Abstract Background: Trimodality therapy seems to be the best treatment for malignant pleural mesothelioma (MPM). A large experience served to…

Read More

Investigation of allergic reactions to platinum salts

Revue des Maladies Respiratoires. 2006 Nov;23(5 Pt 1):458-62. [Link] Touraine F, Sainte Laudy J, Boumediene A, Ndikumwenayo F, Decroisette C, Melloni B, Vergnenegre A, Bonnaud F. Service de Pathologie Respiratoire, CHU de Limoges, Limoges, France. Abstract Introduction: We report two cases occurring in 2004 of patients being treated for pleural mesothelioma with a combination of…

Read More

Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma

Annals of Surgerical Oncology. 2006 Nov 1; [Epub ahead of print] [Link] Xia H, Karasawa K, Hanyu N, Chang TC, Okamoto M, Kiguchi Y, Kawakami M, Itazawa T. Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan. Abstract Background: Prognosis for patients with malignant pleural mesothelioma (MPM) remains poor and such patients require intensive…

Read More